B
y June 27, 2014, 450 confirmed H7N9 human cases resulting in 165 deaths had been reported to the World Health Organization (WHO) 1 , following the identification of the first human case in Eastern China in March 2013 2 . Most human infections are associated with a history of exposure to live poultry markets (LPMs) [3] [4] [5] [6] [7] , and the closure of LPMs is effective at controlling human infection 8, 9 . No human H7N9 cases associated with poultry farms were reported prior to the identification of a poultry farmer infected with the H7N9 virus on February 21, 2014 in Jilin Province in northeastern China 10 . On February 19, 2014 , throat swabs were collected from a 50-year-old male poultry farmer hospitalized in the Jilin University First Hospital, and H7N9 virus was identified 10 as A/Jilin/10117/2014 (H7N9) by the Chinese National Influenza Center (CNIC).
Avian influenza H7N9 virus is a triple-reassortant virus with a hemagglutinin (HA) gene derived from H7N3, a neuraminidase (NA) gene potentially from H7N9, H2N9 or H11N9 and six internal genes derived from H9N2 viruses 2, 4 . It has been proposed that sequential and dynamic genetic reassortment of internal genes generates multiple genotypes of H7N9 viruses with better adaptation [11] [12] [13] [14] ; however, no actual reassortment events in poultry have been discovered to support this hypothesis. This study is the first to describe the reassortment process between H7N9 and H9N2 viruses co-circulating on a poultry farm and resulting in multiple genotypes, one of which was capable of causing human infection. Additionally, the upper and lower bounds of the introduction date of the H7N9 virus to the patient's farm and the upper bound of the reassortment event that led to the human H7N9 strain were estimated using the eight gene segments of the H7N9 and H9N2 viruses. Our findings indicate that poultry farms play an important role, similar to that of LPMs, in the genesis of novel H7N9 reassortments and could act as an important source of human infection. (Table S1 ).
We collected a total of 279 samples from four epidemiologically linked farms (Table 1) as follows: 38 poultry samples and 46 environmental samples from the patient's farm (Site 1); 15 environmental samples from the first dealer's farm and the backyards of the freerange farmers from whom chickens had been obtained and introduced between December 24 and December 27, 2013 (Site 2); 12 poultry samples and 153 environmental samples from the backyards of the free-range farmers in Dongfeng County from whom the second dealer had obtained chickens for the last three batches in February (Site 3); and 6 poultry samples and 9 environmental samples from the backyards of the close contact who developed a fever (Site 4). The viruses were isolated only from the patient's farm, and they included six H7N9 viruses from oropharyngeal or cloacal swabs of chickens and three H9N2 viruses from oropharyngeal swabs of chickens and drinking water.
Molecular markers associated with mammalian adaptation and drug resistance were identified in the H7N9 viruses. Selected amino acid substitutions associated with mammalian adaptation, viral replication and drug resistance were analyzed (Table S2 ). All seven H7N9 viruses, including the human isolate, demonstrated the G186 V mutation in the HA gene and the Q226 L mutation, with the exception of one virus isolated from a chicken that contained 226Q; these results indicated an increased preference for human-like receptor (a2-6) binding 15, 16 . All of the NA genes examined possessed a 69-73 amino acid deletion in the stalk region, which is related to enhanced virulence in mice as well as adaption and transmission in domestic poultry 17 . Although the viruses isolated from the farm contained 701D and 627E, the human isolate, A/ Jilin/10117/2014 (H7N9), possessed a D701N mutation without an E627K mutation in the polymerase basic protein 2 (PB2) gene, which has been proposed to be associated with high polymerase activity and increased virulence in mice 18, 19 . The PB1 L368V mutation, which increases transmission in ferrets 20 , was identified in all of the viruses. The signature amino acids of the human influenza virus polymerase acidic protein (PA) gene were detected, including K356R and S409N 21 . Drug resistance mutations were detected in the matrix protein 2 (M2) gene (S31N); however, the E119V/A/D, R152K, H274Y and R292K mutations were not detected in the NA gene, indicating that the H7N9 viruses were resistant to amantadine and sensitive to NA inhibitors [22] [23] [24] .
Multiple genotypes of H7N9 were generated as a result of cocirculation of H7N9 and H9N2 viruses on the poultry farm. Phylogenetic trees showed that the H7 and N9 genes of the human isolate clustered with the novel H7N9 viruses in the public sequence databases (Fig. S2 in the Supplementary Information). The nucleoprotein (NP), non-structural (NS) and PB1 genes were identified within the major clade, whereas the PB2 and matrix protein (MP) genes fell within the minor clade of the previously reported H7N9 viruses (Fig. S3 in the Supplementary Information). Unlike other segments, the PA gene was different from the H7N9 viruses reported previously and clustered with the H9N2 viruses isolated from the patient's poultry farm (Fig. 1) . With regard to the six internal genes of all the H7N9 and H9N2 isolates, each gene formed two groups (A and B) on the phylogenetic trees ( Fig. S3 in the Supplementary Information). The sequence similarity between the groups of each gene was lower than 99.6% ( Fig. 2a and Tables S5-S10). Seven genotypes were designated, based on the combination of different groups of individual internal genes (Fig. 2c ). The genotype with the combination of ''AABBAA,'' as represented by the A/chicken/Jilin/13188/2014 (H7N9)-like virus (Ck13188-like), and a genotype of ''BBAABB,'' as represented by the A/ chicken/Jilin/13200/2014(H9N2)-like virus (Ck13200-like), provided internal genes as the parental viruses to the other genotypes, including the genotype that caused the human infection (Fig. 2c) . A/Chicken/Jilin/13204/2014(H9N2) and A/Chicken/Jilin/13199/ 2014(H7N9) represent combinations containing two genotypes (Fig. 2b, c) . The likely scenario for the reassortment between the H7N9 and H9N2 viruses co-circulating on the poultry farm is illustrated in Fig. 3 .
The estimated date of the introduction and reassortment of H7N9 viruses. We determined the most recent common ancestors (TMRCAs) and 95% CI for 3 key nodes for each segment using the Bayesian Markov chain Monte Carlo approach in BEAST v1.8 25 as follows: 1) the TMRCA of the viruses isolated from the patient and his farm; 2) the TMRCA of the farm viruses plus the closest viruses isolated elsewhere; and 3) the TMRCA of the human virus and its closest avian virus on the farm. Items (1) and (2) provided the upper and lower bounds of the date of introduction of H7N9 to the farm, respectively, and item (3) provided an upper bound for the date of the occurrence of the reassortment event that led to the human strain. According to our results, as shown in Fig. 4 and Fig. S4 
Discussion
The novel avian influenza A (H7N9) virus is a triple reassortant of H7N3, H7N9 (H2N9, H11N9) and H9N2 viruses with low pathogenicity in poultry 2, 26, 27 ; however, this virus causes severe illness in humans, including rapidly progressive pneumonia, respiratory failure, acute respiratory distress syndrome (ARDS), high rates of intensive care unit (ICU) admission and fatal outcomes 28, 29 . LPM exposure plays a major role in the human risk of H7N9 infections, and LPM closures have reduced the incidence of human infection with the H7N9 virus 9 . Traces of H7N9 were identified recently at a chicken farm in Guangdong Province that supplied poultry to Macau, China 30 . However, no human cases associated with poultry farms were reported before the first patient infected with H7N9 was identified in Jilin in northeastern China 10 . Many studies have suggested that H7N9 underwent dynamic genetic reassortment with H9N2 viruses to generate diversified genotypes [12] [13] [14] 31 . However, the process of generating diversified genotypes has not been observed. In this study, reassortment between H7N9 and H9N2 viruses co-circulating on the same farm was documented (Fig. 3) . Based on the phylogenetic tree and the similarity analysis of six internal genes, the parental Ck13188-like H7N9 and Ck13200-like H9N2 viruses entered the farm and generated four novel genotypes of H7N9 and one genotype of H9N2, with one of the H7N9 genotypes causing human infection. The unique PA gene of the human isolate was different from the genes of previously reported H7N9 viruses; however, the gene was similar to those of the H9N2 viruses isolated from the patient's farm, further supporting the hypothesis that the virus was generated by reassortment between H7N9 and H9N2 coexisting on the farm. No H7N9 viruses had been reported in Jilin prior to the identification of this human infection. The introduction of H7N9 viruses likely occurred between August 21, 2013 (95% CI June 6, 2013-October 6, 2013) and September 25, 2013 (95% CI May 28, 2013-January 4, 2014). According to the epidemiology data, seven batches of poultry were introduced onto the patient's farm, and the virus most likely entered the farm from the first batch, which included 6 turkeys and 33 guinea fowl (N. meleagris) purchased from an agricultural fair in Changchun City in August 2013. Furthermore, the lack of reports showing H7N9 viruses on other epidemiologically linked farms further supports our conclusion of genetic reassortment.
The continued introduction of different species of poultry and the mixed breeding model may have contributed to the diversified genotypes generated by co-circulation of the H7N9 and H9N2 viruses on the patient's farm. Nearly 1,000 birds of five species including chickens, guinea fowl, black-bone Silkie chickens, turkeys and geese were involved in this process. Chickens were the most prevalent poultry species on the patient's farm. Previous studies have suggested that H7N9 and H9N2 predominately circulate in chickens 27, 32 , indicating that the genesis of the diversified genotypes most likely occurred in chickens. However, the mixed breeding model may also facilitate the transmission of H7N9 and H9N2 among different species of poultry and expand the host range. Thus, species other than chickens might contribute to the genesis of different genotypes and human infection on poultry farms.
The H7N9 virus HA protein shows a binding affinity for mammalian receptors; however, no evidence of sustained human-tohuman transmission has been reported. Similar to the findings of previous studies, clinical syndromes were not detected in any close contacts of the patient, except in an individual who developed a fever; influenza A was not detected in this contact. Moreover, traces of H7N9 viruses were not detected in the poultry or envir- onmental samples collected from the backyards of the close contact, and no H7N9 antibody was detected in the paired sera of any of the contacts.
There are some limitations to our study. For instance, a genotype identical to the human isolate was not detected in poultry, which may have been caused by the insufficient sample size. Nevertheless, according to the homology analysis, each gene with high identity (99.9%-100%) to A/Jilin/10117/2014 (H7N9) was detected in the viruses isolated from the poultry farm (Tables S3-S10 ). In addition, we proposed that the possible original source of the introduction of H7N9 was from the first batch of poultry purchased from the agricultural fair in August, 2013; however, without collecting samples from this batch of poultry, the actual original source of H7N9 virus could not be confirmed.
Our findings imply that poultry farms may act as a source for the generation of divergent genotypes of H7N9 viruses and human infection. Extensive poultry farm surveillance is therefore needed for public health security.
Methods
Ethics statement. As a public health response to the outbreak, written informed consent of the study subjects could be waived according to Chinese law. However, we obtained the patient's written informed consent for publication. The clinical sample collection and transportation were performed according to the Chinese Guidelines for the Diagnosis and Treatment of Human Infection with H7N9 Avian Influenza Virus (2 nd edition, 2013). The experimental protocols were approved by the Laboratory Management Committee of the National Institute for Viral Disease Control and Prevention.
Surveillance, reporting and data collection. A standardized surveillance and reporting form was used to collect the epidemiological and clinical data, as follows: demographic characteristics; underlying medical conditions; history of seasonal influenza vaccination; recent exposure to poultry, swine or other animals; recent visits to a live animal market; clinical signs and symptoms; antiviral treatment; clinical complications; and outcomes. Active surveillance was performed by sampling the poultry and the environment of the patient's poultry farm and other possible sources of virus introduction. After identifying the close contacts of the patient, the medical conditions were monitored daily for 7 days after the last known exposure to the patient. Throat swabs were collected from the close contacts who developed clinical symptoms. Serum samples were collected in the acute and convalescent phases from the close contacts of the patient.
RNA extraction and real-time RT-PCR. Viral RNA was extracted using a QIAampH Viral RNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Specific real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays for seasonal influenza viruses (H1, H3 or B) and avian influenza H1 to the H16 and N1 to the N9 subtypes were performed to verify the viral subtypes.
Hemagglutination-inhibition (HI) assay. An improved horse erythrocyte HI assay with a modified order of serum treatment procedures was used to detect antibody response to H7N9 33, 34 . Beta-propriolactone (BPL)-inactivated reference H7N9 virus A/Anhui/1/2013 was used as the antigen in this assay.
Virus isolation and genome sequencing. The specimens were maintained in a viral transport medium and were inoculated and grown in 9-to 10-day-old specific pathogen-free (SPF) embryonated chicken eggs for 48-72 h at 37uC. The full genomes of the virus isolates were amplified with a QiagenOneStep RT-PCR Kit for sequencing (Qiagen, Germany). The PCR products were purified from an agarose gel with a QIAquick Gel Extraction Kit (Qiagen, Germany). Sanger sequencing was performed with an automatic Applied Biosystems 3730xl DNA Analyzer (Life Technologies, USA) and an Applied Biosystems Big Dye Terminator v3.1 Cycle Sequencing Kit (Life Technologies, USA) according to the manufacturer's instructions. Deep sequencing was performed using the Ion torrent PGM platform. The library of 200-bp fragments was sequenced with a 318v2 chip. The nextgeneration sequencing (NGS) reads were analyzed with a pipeline process using the CLC Genomics workbench 7.0.4. The human isolate A/Jilin/10117/2014 and A/ Chicken/Jilin/05/2014 were sequenced by Sanger sequencing. The sequences of other viruses isolated from chickens and the poultry farm environment were examined using deep sequencing with the Ion torrent PGM platform to investigate whether potential avian influenza viruses coexisted in the hosts. The accession codes of the viral sequences isolated in this study are shown in Table S11 .
Genetic analysis. The percentage of each viral gene that was identified was calculated using MegAlign7.1. The datasets were obtained from the Global Initiative on Sharing All Influenza Data (GISAID) EpiFlu TM Database. A maximum likelihood phylogenetic tree for the nucleotide sequences of each gene of the selected influenza viruses was constructed with MEGA5.1. The bootstrap method was used to test the phylogeny and was run up to 1,000 times. The time in generations to TMRCA for the eight gene fragments was estimated with the Bayesian Markov chain Monte Carlo (MCMC) approach in BEAST v1.8 25 using the SRD06 nucleotide substitution model 35 . The uncorrelated lognormal relaxed clock model was selected for the rate variation among the branches. A Bayesian skyride was used as a prior coalescent tree, and the UPGMA tree was used as the starting tree. For the prior parameter, ucld.mean and ucld.stdev were set as the uniform distributions; the default values of the other parameters were used. The virus isolates without a detailed sampling date were assigned to the middle of the year/month. The MCMC algorithm was run for 5 3 10
